Neil Strickman, MD
See Publications

Texas Heart Institute Positions

  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Interventional Cardiology Fellowship
  • Editorial Consultant, Texas Heart Institute Journal

Interests

Education

  • Medical School:

    Medical Center College of Medicine at Syracuse

  • Internship:

    University of Texas Health Science Center at Houston

  • Fellowships:

    Texas Heart Institute

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Baylor St. Luke's Medical Center
  • Hall-Garcia Cardiology at Baylor College of Medicine

Honors, Awards and Memberships

Publications

4862227 YQ6XGPLC 1 alternatives-to-animal-experimentation 10 date desc Strickman 2118 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22FX9G9FLJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Postalian%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPostalian%2C%20A.%2C%20Kuchibhotla%2C%20S.%2C%20Koneru%2C%20S.%20et%20al.%20%282022%29.%20A%20special%20clinical%20scenario%20for%20transcatheter%20aortic%20valve%20replacement%3A%20%26%23x201C%3Biatrogenic%20double-outlet%26%23x201D%3B%20left%20ventricle.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B49%26lt%3B%5C%2Fi%26gt%3B%2C%20e227889.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-22-7889%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-22-7889%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20special%20clinical%20scenario%20for%20transcatheter%20aortic%20valve%20replacement%3A%20%5C%22iatrogenic%20double-outlet%5C%22%20left%20ventricle%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Postalian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudeep%22%2C%22lastName%22%3A%22Kuchibhotla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%5D%2C%22abstractNote%22%3A%22A%2067-year-old%20man%20with%20a%20history%20of%20chest%20radiotherapy%20and%20severe%20aortic%20valve%20stenosis%20with%20calcification%20of%20the%20ascending%20aortic%20wall%20underwent%20implantation%20of%20an%20apicoaortic%20conduit%20from%20the%20left%20ventricular%20apex%20to%20the%20descending%20aorta.%20Eight%20years%20later%2C%20he%20presented%20with%20progressive%20exertional%20dyspnea.%20Imaging%20revealed%20severe%20native%20aortic%20valve%20insufficiency%20and%20calcification%2C%20with%20worsening%20left%20ventricular%20function.%20We%20decided%20to%20leave%20the%20apicoaortic%20conduit%20intact%20and%20perform%20transcatheter%20aortic%20valve%20replacement%20with%20a%20balloon-expandable%20prosthesis.%20Despite%20concerns%20that%20eliminating%20the%20obstruction%20across%20the%20native%20left%20ventricular%20outflow%20tract%20might%20decrease%20conduit%20flow%20and%20eventually%20cause%20graft%20thrombosis%20and%20peripheral%20embolization%2C%20we%20elected%20to%20move%20forward%20after%20a%20multidisciplinary%20discussion.%20The%20procedure%20resulted%20in%20angiographically%20and%20qualitatively%20similar%20forward%20flow%20across%20the%20newly%20implanted%20prosthesis%20and%20the%20existing%20apicoaortic%20conduit%2C%20with%20no%20hemodynamic%20or%20electrical%20dysfunction.%20The%20patient%20was%20discharged%20from%20the%20hospital%20the%20next%20day.%20At%20the%201-month%20follow-up%20visit%2C%20the%20patient%20felt%20well%20and%20reported%20marked%20functional%20improvement%2C%20with%20minimal%20symptoms%20during%20moderate%20to%20heavy%20exertion.%20The%20stroke%20volume%20index%20across%20the%20new%20bioprosthetic%20valve%20was%20low%20%2813%20mL%5C%2Fm2%20at%201%20mo%20and%2018%20mL%5C%2Fm2%20at%201%20y%29%2C%20suggesting%20that%20a%20substantial%20amount%20of%20blood%20was%20still%20exiting%20the%20ventricle%20through%20the%20left%20ventricle-to-aorta%20conduit.%20This%20report%20offers%20some%20guidance%20for%20treating%20patients%20with%20existing%20apicoaortic%20conduits%20and%20suggests%20that%20transcatheter%20aortic%20valve%20replacement%20is%20safe%20and%20effective%20if%20native%20aortic%20valve%20insufficiency%20develops.%22%2C%22date%22%3A%22Sept%2001%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-22-7889%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YQ6XGPLC%22%2C%22849YWXRD%22%2C%22DDIGS78H%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%2C%22X2D36SJL%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A23%3A42Z%22%7D%7D%2C%7B%22key%22%3A%225EH5PNVH%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Postalian%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPostalian%2C%20A.%2C%20%26lt%3Bstrong%26gt%3BStrickman%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20E.%2C%20Costello%2C%20B.%20T.%20et%20al.%20%282021%29.%20%26%23x201C%3BSimple%26%23x201D%3B%20transcatheter%20aortic%20valve%20replacement%20with%20conscious%20sedation%3A%20Safety%20and%20effectiveness%20in%20real-world%20practice.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20e207528.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.10453%5C%2FTHIJ-20-7528%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.10453%5C%2FTHIJ-20-7528%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5C%22Simple%5C%22%20transcatheter%20aortic%20valve%20replacement%20with%20conscious%20sedation%3A%20Safety%20and%20effectiveness%20in%20real-world%20practice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Postalian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Briana%20T.%22%2C%22lastName%22%3A%22Costello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%5D%2C%22abstractNote%22%3A%22Transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20is%20a%20well-established%20alternative%20to%20open%20surgical%20replacement.%20Strictly%20selecting%20low-risk%20patients%20and%20using%20conscious%20sedation%20during%20TAVR%20has%20enabled%20hospital%20stays%20to%20be%20safely%20shortened.%20We%20evaluated%20the%20safety%20and%20effectiveness%20of%20a%20less%20rigorous%20patient-selection%20process%20involving%20multidisciplinary%20case%20discussions%2C%20percutaneous%20procedures%20with%20the%20use%20of%20conscious%20sedation%2C%20and%20postprocedural%20care%20outside%20an%20intensive%20care%20unit%2C%20with%20the%20goal%20of%20discharging%20patients%20from%20the%20hospital%20early.%20We%20call%20this%20%26quot%3Bsimple%20TAVR.%26quot%3B%20We%20retrospectively%20reviewed%20the%20records%20of%20patients%20who%20underwent%20TAVR%20from%20March%202015%20through%20February%202020%20at%20our%20center.%20The%20procedures%20were%20performed%20by%202%20high-volume%20operators.%20Of%20524%20total%20procedures%2C%20344%20%2865.6%25%29%20qualified%20as%20simple%20TAVR.%20All%20344%20procedures%20were%20successful.%20The%20highest%2030-day%20complication%20rate%20was%20associated%20with%20new%20permanent%20pacemaker%20implantation%20%287.3%25%2C%2025%20patients%29%3B%20the%20rates%20of%20major%20vascular%20complications%2C%20stroke%2C%20and%20all-cause%20death%20were%20less%20than%203%25%20each.%20Of%20note%2C%20252%20patients%20%2873.3%25%29%20were%20discharged%20from%20the%20hospital%20the%20day%20after%20TAVR%2C%20and%20307%20%2889.2%25%29%20within%2048%20hours.%20Simple%20TAVR%20is%20safe%2C%20economical%2C%20and%20feasible%20in%20real-world%20practice%2C%20and%20it%20does%20not%20necessitate%20a%20rigorous%20perioperative%20protocol%20or%20patient-selection%20process.%22%2C%22date%22%3A%22Sept%2001%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.10453%5C%2FTHIJ-20-7528%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%223WHLRQCH%22%2C%22YQ6XGPLC%22%2C%22849YWXRD%22%2C%22QSVIJDTT%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222021-10-29T19%3A44%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22EFZ9YY7A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Koneru%2C%20S.%2C%20Krajcer%2C%20Z.%20et%20al.%20%282021%29.%20Hemodynamic%20outcomes%20after%20valve-in-valve%20transcatheter%20aortic%20valve%20replacement%3A%20a%20single-center%20experience.%20%26lt%3Bi%26gt%3BAnn%20Cardiothorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20630%26%23x2013%3B640.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21037%5C%2Facs-2021-tviv-131%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21037%5C%2Facs-2021-tviv-131%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hemodynamic%20outcomes%20after%20valve-in-valve%20transcatheter%20aortic%20valve%20replacement%3A%20a%20single-center%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Yazan%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20L.%22%2C%22lastName%22%3A%22McCormack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Briana%20T.%22%2C%22lastName%22%3A%22Costello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%20Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20G.%22%2C%22lastName%22%3A%22D%5Cu00edez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Sept%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.21037%5C%2Facs-2021-tviv-131%22%2C%22ISSN%22%3A%222225319X%2C%2023041021%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.annalscts.com%5C%2Farticle%5C%2Fview%5C%2F16858%5C%2Fhtml%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YL3LPZGE%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22QSVIJDTT%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222022-05-12T20%3A43%3A50Z%22%7D%7D%2C%7B%22key%22%3A%223SXXRRI8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Harrison%2C%20D.%2C%20Preventza%2C%20O.%20et%20al.%20%282021%29.%20Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis.%20%26lt%3Bi%26gt%3BInt%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B329%26lt%3B%5C%2Fi%26gt%3B%2C%2050%26%23x2013%3B55.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%20Y.%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20A.%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Palaskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Fish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20F.%22%2C%22lastName%22%3A%22Stainback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Chest%20radiation%20therapy%20%28CRT%29%20for%20malignant%20thoracic%20neoplasms%20is%20associated%20with%20development%20of%20valvular%20heart%20disease%20years%20later.%20As%20previous%20radiation%20exposure%20can%20complicate%20surgical%20treatment%2C%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20has%20emerged%20as%20an%20alternative.%20However%2C%20outcomes%20data%20are%20lacking%20for%20TAVR%20patients%20with%20a%20history%20of%20CRT.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20study%20of%20all%20patients%20who%20underwent%20a%20TAVR%20procedure%20at%20a%20single%20institution%20between%20September%202012%20and%20November%202018.%20Among%201341%20total%20patients%2C%2050%20had%20previous%20CRT.%20These%20were%20propensity-matched%20in%20a%201%3A2%20ratio%20to%20100%20patients%20without%20history%20of%20CRT.%20Thirty-day%20adverse%20events%20were%20analyzed%20with%20generalized%20estimating%20equation%20models.%20Overall%20mortality%20was%20analyzed%20with%20stratified%20Cox%20regression%20modelling.%5CnRESULTS%3A%20Median%20clinical%20follow-up%20was%2024%5Cu00a0months%20%28interquartile%20range%20%5BIQR%5D%2C%2012-44%5Cu00a0months%29.%20There%20was%20no%20difference%20between%20CRT%20and%20non-CRT%20patients%20in%20overall%20mortality%20%28hazard%20ratio%20%5BHR%5D%200.84%20%5B0.37-1.90%5D%2C%20P%5Cu00a0%3D%5Cu00a00.67%29%2C%2030-day%20mortality%20%28HR%203.1%20%5B0.49-20.03%5D%2C%20P%5Cu00a0%3D%5Cu00a00.23%29%2C%20or%2030-day%20readmission%20rate%20%28HR%201.0%20%5B0.43-2.31%5D%2C%20P%5Cu00a0%3D%5Cu00a01%29.%20There%20were%20no%20differences%20in%20the%20rates%20of%20most%20adverse%20events%2C%20but%20patients%20with%20CRT%20history%20had%20higher%20rates%20of%20postprocedural%20respiratory%20failure%20%28HR%203.63%20%5B1.32-10.02%5D%2C%20P%5Cu00a0%3D%5Cu00a00.01%29%20and%20permanent%20pacemaker%20implantation%20%28HR%202.84%20%5B1.15-7.01%5D%2C%20P%5Cu00a0%3D%5Cu00a00.02%29.%5CnCONCLUSIONS%3A%20For%20patients%20with%20aortic%20valve%20stenosis%20and%20previous%20CRT%2C%20TAVR%20is%20safe%20and%20effective%2C%20with%20outcomes%20similar%20to%20those%20in%20the%20general%20aortic%20stenosis%20population.%20Patients%20with%20history%20of%20CRT%20are%20more%20likely%20to%20have%20postprocedural%20respiratory%20failure%20and%20to%20require%20permanent%20pacemaker%20implantation.%22%2C%22date%22%3A%22Apr%2015%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcard.2020.12.054%22%2C%22ISSN%22%3A%221874-1754%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YRK99JHR%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22AAQ89W3S%22%2C%22X6Y3USZ6%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A27%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22F843LN68%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Geraghty%20et%20al.%22%2C%22parsedDate%22%3A%222021-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGeraghty%2C%20P.%20J.%2C%20Adams%2C%20G.%2C%20Schmidt%2C%20A.%20et%20al.%20%282021%29.%20Six-month%20pivotal%20results%20of%20tack%20optimized%20balloon%20angioplasty%20using%20the%20Tack%20Endovascular%20System%20in%20below-the-knee%20arteries.%20%26lt%3Bi%26gt%3BJ%20Vasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B73%26lt%3B%5C%2Fi%26gt%3B%2C%20918-929.e5.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvs.2020.08.135%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvs.2020.08.135%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Six-month%20pivotal%20results%20of%20tack%20optimized%20balloon%20angioplasty%20using%20the%20Tack%20Endovascular%20System%20in%20below-the-knee%20arteries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20J.%22%2C%22lastName%22%3A%22Geraghty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Adams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrej%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22TOBA%20II%20BTK%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20No%20vascular%20implant%20is%20commercially%20available%20in%20the%20United%20States%20to%20treat%20post-angioplasty%20dissections%20in%20below-the-knee%20%28BTK%29%20arteries.%20The%20Tack%20Endovascular%20System%20%28Intact%20Vascular%2C%20Wayne%2C%20Pa%29%20is%20purpose-built%20to%20repair%20postpercutaneous%20transluminal%20angioplasty%20%28PTA%29%20BTK%20dissections.%20A%20trial%20was%20conducted%20to%20investigate%20the%20safety%20and%20efficacy%20of%20the%20first-of-a-kind%20implantable%20BTK%20device%20to%20treat%20post-PTA%20dissections%20in%20the%20setting%20of%20critical%20limb%20ischemia.%5CnMETHODS%3A%20The%20present%20prospective%2C%20single-arm%2C%20multicenter%20study%20evaluated%20the%20Tack%20Endovascular%20System%20for%20treating%20post-PTA%20dissections%20in%20the%20mid%5C%2Fdistal%20popliteal%2C%20tibial%2C%20and%20peroneal%20arteries.%20The%20primary%20safety%20endpoint%20was%20major%20adverse%20limb%20events%20%28MALE%29%20plus%20perioperative%20death%20%28POD%29%2C%20assessed%20at%2030%5Cu00a0days%20after%20the%20index%20procedure.%20The%20primary%20efficacy%20endpoint%20was%20a%20composite%20of%20MALE%20at%206%5Cu00a0months%20and%20POD.%20The%20unpowered%20secondary%20endpoint%20was%20primary%20patency%20at%206%5Cu00a0months.%20With%20no%20available%20on-label%20comparator%2C%20the%20primary%20endpoints%20of%20the%20present%20trial%20were%20determined%20using%20objective%20performance%20goals%20from%20a%20systematic%20literature%20search.%20The%20secondary%20endpoints%20included%20Tacked%20segment%20patency%20and%20target%20limb%20salvage%20at%206%5Cu00a0months.%20The%206-month%20results%20are%20reported.%5CnRESULTS%3A%20Of%20the%20233%20patients%20enrolled%2C%20117%20%2850.2%25%29%20had%20Rutherford%20class%205%20and%2078%20%2833.5%25%29%20had%20Rutherford%20class%204.%20A%20total%20of%20341%20post-PTA%20dissections%20were%20treated.%20Each%20patient%20received%20at%20least%20one%20Tack%20implant%2C%20and%20100%25%20of%20the%20dissections%20resolved%20according%20to%20the%20angiographic%20core%20laboratory%20findings.%20The%20primary%20safety%20and%20efficacy%20endpoints%20were%20both%20met.%20The%20rate%20of%20MALE%20plus%20POD%20at%2030%5Cu00a0days%20was%201.3%25%20%283%20of%20228%29%20and%20freedom%20from%20MALE%20at%206%5Cu00a0months%20plus%20POD%20at%2030%5Cu00a0days%20was%2095.6%25%20%28196%20of%20205%29.%20The%206-month%20Tacked%20segment%20patency%20was%2082.1%25%20%28247%20of%20301%29%20and%20target%20limb%20salvage%20was%2098.5%25%20%28202%20of%20205%29.%20The%20Kaplan-Meier%20freedom%20from%20clinically%20driven%20target%20lesion%20revascularization%20and%20amputation-free%20survival%20at%206%5Cu00a0months%20was%2092.0%25%20and%2095.7%25%2C%20respectively.%20Rutherford%20improvement%20was%20reported%20in%2079.4%25%20%28158%20of%20199%29.%20Most%20%2890%20of%20122%3B%2073.8%25%29%20preexisting%20wounds%20had%20healed%20or%20were%20improving.%5CnCONCLUSIONS%3A%20The%20Tack%20Endovascular%20System%20is%20safe%20and%20effective%20for%20treating%20post-PTA%20BTK%20dissections%20through%206%5Cu00a0months%2C%20with%20favorable%20rates%20of%20MALE%20plus%20POD%2C%20patency%2C%20clinically%20driven%20target%20lesion%20revascularization%2C%20limb%20salvage%2C%20and%20wound%20healing.%22%2C%22date%22%3A%22Mar%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jvs.2020.08.135%22%2C%22ISSN%22%3A%221097-6809%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YQ6XGPLC%22%5D%2C%22dateModified%22%3A%222021-03-22T15%3A42%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22GY9Q7GU3%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Geraghty%20et%20al.%22%2C%22parsedDate%22%3A%222020-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGeraghty%2C%20P.%20J.%2C%20Adams%2C%20G.%20L.%2C%20Schmidt%2C%20A.%20et%20al.%20%282020%29.%20Twelve-month%20results%20of%20Tack-optimized%20balloon%20angioplasty%20using%20the%20Tack%20endovascular%20system%20in%20below-the-knee%20arteries%20%28TOBA%20II%20BTK%29.%20%26lt%3Bi%26gt%3BJ%20Endovasc%20Ther%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%20626%26%23x2013%3B636.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F1526602820944402%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F1526602820944402%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Twelve-month%20results%20of%20Tack-optimized%20balloon%20angioplasty%20using%20the%20Tack%20endovascular%20system%20in%20below-the-knee%20arteries%20%28TOBA%20II%20BTK%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20J.%22%2C%22lastName%22%3A%22Geraghty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20L.%22%2C%22lastName%22%3A%22Adams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrej%22%2C%22lastName%22%3A%22Schmidt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Lichtenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Wissgott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ehrin%20J.%22%2C%22lastName%22%3A%22Armstrong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Klaus%22%2C%22lastName%22%3A%22Hertting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22TOBA%20II%20BTK%20investigators%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%3A%20To%20report%20the%2012-month%20safety%20and%20efficacy%20outcomes%20of%20the%20investigational%20device%20exemption%20trial%20evaluating%20an%20implantable%20below-the-knee%20%28BTK%29%20dissection%20repair%20device.%20Materials%20and%20Methods%3A%20The%20prospective%2C%20multicenter%2C%20single-arm%20Tack-Optimized%20Balloon%20Angioplasty%20%28TOBA%29%20II%20BTK%20study%20%28ClinicalTrials.gov%20identifier%20NCT02942966%29%20evaluated%20the%20Tack%20Endovascular%20System%20in%20the%20BTK%20arteries%20vs%20objective%20performance%20goals%20derived%20from%20a%20systematic%20review%20of%20BTK%20angioplasty%20literature.%20Patients%20presenting%20with%20Rutherford%20category%203-5%20ischemia%20were%20eligible%20and%20were%20enrolled%20during%20the%20procedure%20if%20angioplasty%20resulted%20in%20dissection%28s%29%20of%20the%20BTK%20arteries.%20Between%20February%202017%20and%20December%202018%2C%20the%20study%20enrolled%20233%20patients%20%28mean%20age%2074.4%5Cu00b110.0%20years%3B%20157%20men%29.%20Most%20lesions%20%2893.8%25%29%20were%20de%20novo%3B%20almost%20half%20%28118%5C%2F248%2C%2047.6%25%29%20were%20total%20occlusions.%20Mean%20target%20lesion%20length%20was%2080%5Cu00b149%20mm.%20Moderate%20to%20severe%20calcium%20was%20present%20in%2089%20%2835.8%25%29%20lesions.%20The%2030-day%20primary%20safety%20endpoint%20was%20a%20composite%20of%20major%20adverse%20limb%20events%20%28MALE%29%20and%20all-cause%20perioperative%20death%20%28POD%29.%20The%20primary%20efficacy%20endpoint%20was%20a%20composite%20of%20MALE%20at%206%20months%20and%2030-day%20POD.%20These%20safety%20and%20efficacy%20endpoints%20were%20assessed%20at%2012%20months%20as%20observational%20endpoints%20along%20with%20amputation-free%20survival%20%28AFS%29%2C%20freedom%20from%20clinically-driven%20target%20lesion%20revascularization%20%28CD-TLR%29%2C%20vessel%20patency%2C%20and%20changes%20from%20baseline%20in%20clinical%20and%20quality%20of%20life%20measures.%20Results%3A%20All%20patients%20had%20post-PTA%20dissection%20and%20received%20at%20least%201%20Tack%20implant%20%28range%201%20to%2016%29.%20The%20angiographic%20core%20laboratory%20noted%20successful%20resolution%20of%20100%25%20of%20the%20341%20treated%20dissections.%20At%2012%20months%2C%2093.4%25%20%28170%5C%2F182%29%20of%20patients%20remained%20free%20of%20the%20composite%20endpoint%20of%20MALE%20%2B%20POD.%20Tacked%20segment%20patency%20was%2081.3%25%20and%20limb%20salvage%20was%2096.8%25%20at%2012%20months%3B%20freedom%20from%20CD-TLR%20and%20AFS%20were%2083.1%25%20and%2089.3%25%2C%20respectively.%20Sustained%20Rutherford%20category%20improvement%20was%20reported%20in%2082.4%25%20of%20evaluated%20patients%2C%20with%2062.4%25%20improving%20%5Cu22653%20categories%20%28p%26lt%3B0.001%29.%20Ninety%20of%20124%20index%20wounds%20%2872.5%25%29%20healed%20or%20improved.%20Conclusion%3A%20The%20Tack%20Endovascular%20System%20is%20safe%20and%20effective%20in%20the%20treatment%20of%20post-angioplasty%20BTK%20dissections.%20Twelve-month%20outcome%20data%20from%20the%20TOBA%20II%20BTK%20study%20demonstrate%20high%20rates%20of%20patency%2C%20limb%20salvage%2C%20and%20wound%20healing.%22%2C%22date%22%3A%22Aug%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F1526602820944402%22%2C%22ISSN%22%3A%221545-1550%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YQ6XGPLC%22%2C%22WC4XX237%22%5D%2C%22dateModified%22%3A%222022-02-25T20%3A53%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22EQDVXRA6%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Krajcer%20et%20al.%22%2C%22parsedDate%22%3A%222020-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKrajcer%2C%20Z.%2C%20Wood%2C%20D.%20A.%2C%20%26lt%3Bstrong%26gt%3BStrickman%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20et%20al.%20%282020%29.%20Pivotal%20clinical%20study%20to%20evaluate%20the%20safety%20and%20effectiveness%20of%20the%20MANTA%20vascular%20closure%20device%20during%20percutaneous%20EVAR%20and%20TEVAR%20procedures.%20%26lt%3Bi%26gt%3BJ%20Endovasc%20Ther%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B27%26lt%3B%5C%2Fi%26gt%3B%2C%20414%26%23x2013%3B420.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F1526602820912224%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F1526602820912224%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pivotal%20clinical%20study%20to%20evaluate%20the%20safety%20and%20effectiveness%20of%20the%20MANTA%20vascular%20closure%20device%20during%20percutaneous%20EVAR%20and%20TEVAR%20procedures%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nelson%22%2C%22lastName%22%3A%22Bernardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Metzger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Aziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Michael%22%2C%22lastName%22%3A%22Bacharach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aravinda%22%2C%22lastName%22%3A%22Nanjundappa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20T.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20D.%22%2C%22lastName%22%3A%22Dake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Lumsden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Nardone%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%3A%20To%20evaluate%20the%20safety%20and%20effectiveness%20of%20the%20MANTA%20percutaneous%20vascular%20closure%20device%20in%20patients%20undergoing%20percutaneous%20endovascular%20aneurysm%20repair%20%28PEVAR%29%20or%20thoracic%20endovascular%20aortic%20repair%20%28TEVAR%29.%20Materials%20and%20Methods%3A%20The%20SAFE%20MANTA%20Study%20%28ClinicalTrials.gov%20identifier%20NCT02908880%29%20was%20a%20prospective%2C%20single-arm%2C%20multicenter%20trial%20in%20patients%20undergoing%20endovascular%20interventions%20using%20large-bore%20sheaths%20%28transcatheter%20aortic%20valve%20replacement%2C%20PEVAR%2C%20or%20TEVAR%29%20at%2020%20sites%20in%20North%20America.%20Patient%20selection%20intended%20to%20test%20the%20MANTA%20device%20in%20populations%20without%20morbid%20obesity%2C%20severe%20calcification%2C%20or%20a%20severely%20scarred%20femoral%20access%20area.%20Of%20the%20263%20patients%20enrolled%20in%20the%20primary%20analysis%20cohort%2C%2053%20%2820.2%25%29%20patients%20%28mean%20age%2074.9%5Cu00b18.9%20years%3B%2041%20men%29%20underwent%20PEVAR%20%28n%3D51%29%20or%20TEVAR%20%28n%3D2%29%20procedures%20and%20form%20the%20cohort%20for%20this%20subgroup%20analysis.%20Per%20protocol%20a%20single%20MANTA%20device%20was%20deployed%20in%20all%20PEVAR%5C%2FTEVAR%20cases.%20Results%3A%20The%20mean%20time%20to%20hemostasis%20in%20the%20PEVAR%5C%2FTEVAR%20cohort%20was%2035%5Cu00b191%20seconds%2C%20with%20a%20median%20time%20of%2019%20seconds%20vs%2024%20seconds%20in%20the%20overall%20SAFE%20MANTA%20population.%20The%20MANTA%20device%20met%20the%20definition%20for%20technical%20success%20in%2052%20%2898%25%29%20of%2053%20PEVAR%5C%2FTEVAR%20cases%20compared%20with%2097.7%25%20in%20the%20overall%20SAFE%20MANTA%20population.%20One%20%281.9%25%29%20major%20complication%20%28access-site%20stenosis%29%20occurred%20in%20this%20subgroup%20compared%20to%2014%20%285.3%25%29%20events%20in%20the%20SAFE%20population.%20In%20the%20PEVAR%5C%2FTEVAR%20group%2C%201%20pseudoaneurysm%20was%20noted%20prior%20to%20discharge%2C%20another%20at%2030-day%20follow-up%2C%20and%20one%20at%2060%20days.%20One%20%281.9%25%29%20of%20the%203%20minor%20pseudoaneurysms%20was%20treated%20with%20ultrasound-guided%20compression%20and%20the%20other%202%20required%20no%20treatment.%20Conclusion%3A%20The%20MANTA%20device%20demonstrated%20a%20short%20time%20to%20hemostasis%20and%20low%20complication%20rates%20compared%20with%20published%20literature%20results%20of%20other%20percutaneous%20closure%20devices.%20Time%20to%20hemostasis%20and%20complication%20rates%20were%20comparable%20between%20the%20PEVAR%5C%2FTEVAR%20patients%20and%20the%20full%20SAFE%20MANTA%20study%20cohort.%20The%20MANTA%20device%20provides%20reliable%20closure%20with%20a%20single%20percutaneous%20device%20for%20PEVAR%5C%2FTEVAR%20procedures.%22%2C%22date%22%3A%22Jun%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F1526602820912224%22%2C%22ISSN%22%3A%221545-1550%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%223WHLRQCH%22%2C%22YQ6XGPLC%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222020-07-15T14%3A40%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22UIILSUGL%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wood%20et%20al.%22%2C%22parsedDate%22%3A%222019-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWood%2C%20D.%20A.%2C%20Krajcer%2C%20Z.%2C%20Sathananthan%2C%20J.%20et%20al.%20%282019%29.%20Pivotal%20clinical%20study%20to%20evaluate%20the%20safety%20and%20effectiveness%20of%20the%20MANTA%20percutaneous%20vascular%20closure%20device.%20%26lt%3Bi%26gt%3BCirc%20Cardiovasc%20Interv%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%20e007258.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCINTERVENTIONS.119.007258%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCINTERVENTIONS.119.007258%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pivotal%20clinical%20study%20to%20evaluate%20the%20safety%20and%20effectiveness%20of%20the%20MANTA%20percutaneous%20vascular%20closure%20device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Wood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janarthanan%22%2C%22lastName%22%3A%22Sathananthan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Metzger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Fearon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Aziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lowell%20F.%22%2C%22lastName%22%3A%22Satler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ron%22%2C%22lastName%22%3A%22Waksman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marvin%22%2C%22lastName%22%3A%22Eng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samir%22%2C%22lastName%22%3A%22Kapadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%22%2C%22lastName%22%3A%22Greenbaum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%22%2C%22lastName%22%3A%22Szerlip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Heimansohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Sampson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Coady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roberto%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amar%22%2C%22lastName%22%3A%22Krishnaswamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20T.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Itsik%22%2C%22lastName%22%3A%22Ben-Dor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sina%22%2C%22lastName%22%3A%22Moainie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susheel%22%2C%22lastName%22%3A%22Kodali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adnan%20K.%22%2C%22lastName%22%3A%22Chhatriwalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pradeep%22%2C%22lastName%22%3A%22Yadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22O%27Neill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Kozak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M.%22%2C%22lastName%22%3A%22Bacharach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ted%22%2C%22lastName%22%3A%22Feldman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayra%22%2C%22lastName%22%3A%22Guerrero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aravinda%22%2C%22lastName%22%3A%22Nanjundappa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Bersin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ming%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srinivasa%22%2C%22lastName%22%3A%22Potluri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Colin%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nelson%22%2C%22lastName%22%3A%22Bernardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Lumsden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Barleben%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Dake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathaniel%22%2C%22lastName%22%3A%22Maor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Nardone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%22%2C%22lastName%22%3A%22Lauck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20W.%22%2C%22lastName%22%3A%22O%27Neill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20G.%22%2C%22lastName%22%3A%22Webb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22SAFE%20MANTA%20Study%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Open%20surgical%20closure%20and%20small-bore%20suture-based%20preclosure%20devices%20have%20limitations%20when%20used%20for%20transcatheter%20aortic%20valve%20replacement%2C%20percutaneous%20endovascular%20abdominal%20aortic%20aneurysm%20repair%2C%20or%20percutaneous%20thoracic%20endovascular%20aortic%20aneurysm%20repair.%20The%20MANTA%20vascular%20closure%20device%20is%20a%20novel%20collagen-based%20technology%20designed%20to%20close%20large%20bore%20arteriotomies%20created%20by%20devices%20with%20an%20outer%20diameter%20ranging%20from%2012F%20to%2025F.%20In%20this%20study%2C%20we%20determined%20the%20safety%20and%20effectiveness%20of%20the%20MANTA%20vascular%20closure%20device.%5CnMETHODS%20AND%20RESULTS%3A%20A%20prospective%2C%20single%20arm%2C%20multicenter%20investigation%20in%20patients%20undergoing%20transcatheter%20aortic%20valve%20replacement%2C%20percutaneous%20endovascular%20abdominal%20aortic%20aneurysm%20repair%2C%20or%20thoracic%20endovascular%20aortic%20aneurysm%20repair%20at%2020%20sites%20in%20North%20America.%20The%20primary%20outcome%20was%20time%20to%20hemostasis.%20The%20primary%20safety%20outcomes%20were%20accessed%20site-related%20vascular%20injury%20or%20bleeding%20complications.%20A%20total%20of%20341%20patients%2C%2078%20roll-in%2C%20and%20263%20in%20the%20primary%20analysis%20cohort%2C%20were%20entered%20in%20the%20study%20between%20November%202016%20and%20September%202017.%20For%20the%20primary%20analysis%20cohort%2C%20transcatheter%20aortic%20valve%20replacement%20was%20performed%20in%20210%20%2879.8%25%29%2C%20and%20percutaneous%20endovascular%20abdominal%20aortic%20aneurysm%20repair%20or%20thoracic%20endovascular%20aortic%20aneurysm%20repair%20was%20performed%20in%2053%20%2820.2%25%29.%20The%2014F%20MANTA%20was%20used%20in%2042%20cases%20%2816%25%29%2C%20and%20the%2018F%20was%20used%20in%20221%20cases%2884%25%29.%20The%20mean%20effective%20sheath%20outer%20diameter%20was%2022F%20%287.3%20mm%29.%20The%20mean%20time%20to%20hemostasis%20was%2065%5Cu00b1157%20seconds%20with%20a%20median%20time%20to%20hemostasis%20of%2024%20seconds.%20Technical%20success%20was%20achieved%20in%20257%20%2897.7%25%29%20patients%2C%20and%20a%20single%20device%20was%20deployed%20in%20262%20%2899.6%25%29%20of%20cases.%20Valve%20Academic%20Research%20Consortium-2%20major%20vascular%20complications%20occurred%20in%2011%20%284.2%25%29%20cases%3A%204%20received%20a%20covered%20stent%20%281.5%25%29%2C%203%20had%20access%20site%20bleeding%20%281.1%25%29%2C%202%20underwent%20surgical%20repair%20%280.8%25%29%2C%20and%202%20underwent%20balloon%20inflation%20%280.8%25%29.%5CnCONCLUSIONS%3A%20In%20a%20selected%20population%2C%20this%20study%20demonstrated%20that%20the%20MANTA%20percutaneous%20vascular%20closure%20device%20can%20safely%20and%20effectively%20close%20large%20bore%20arteriotomies%20created%20by%20current%20generation%20transcatheter%20aortic%20valve%20replacement%2C%20percutaneous%20endovascular%20abdominal%20aortic%20aneurysm%20repair%2C%20and%20thoracic%20endovascular%20aortic%20aneurysm%20repair%20devices.%5CnCLINICAL%20TRIAL%20REGISTRATION%3A%20URL%3A%20https%3A%5C%2F%5C%2Fwww.clinicaltrials.gov%20.%20Unique%20identifier%3A%20NCT02908880.%22%2C%22date%22%3A%22Jul%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCINTERVENTIONS.119.007258%22%2C%22ISSN%22%3A%221941-7632%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%223WHLRQCH%22%2C%22YQ6XGPLC%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222019-08-09T20%3A00%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22ITFR4KES%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Almanfi%20et%20al.%22%2C%22parsedDate%22%3A%222017-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAlmanfi%2C%20A.%2C%20Qurie%2C%20A.%20and%20%26lt%3Bstrong%26gt%3BStrickman%26lt%3B%5C%2Fstrong%26gt%3B%2C%20N.%20%282017%29.%20Aorto-right%20ventricular%20shunt%20after%20TAVR%3A%20rare%20complication%20of%20common%20procedure.%20%26lt%3Bi%26gt%3BCase%20Rep%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B2017%26lt%3B%5C%2Fi%26gt%3B%2C%201834394.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2017%5C%2F1834394%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2017%5C%2F1834394%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Aorto-right%20ventricular%20shunt%20after%20TAVR%3A%20rare%20complication%20of%20common%20procedure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdelkader%22%2C%22lastName%22%3A%22Almanfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmad%22%2C%22lastName%22%3A%22Qurie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%22%2C%22lastName%22%3A%22Strickman%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20The%20primary%20treatment%20of%20symptomatic%20aortic%20stenosis%20is%20aortic%20valve%20replacement.%20Instead%20of%20open%20chest%20surgery%2C%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20is%20an%20alternative%20intervention%20for%20high-risk%20surgical%20candidates.%5CnClinical%20Case%3A%20A%2092-year-old%20male%20presented%20with%20progressive%20exertional%20dyspnea%20and%20recurrent%20syncopal%20attacks%20secondary%20to%20severe%20AS.%20The%20patient%20underwent%20successful%20transfemoral%20TAVR%20with%2029%5Cu2009mm%20Edwards%20SAPIEN%20XT%20valve.%20His%20postoperative%20course%20was%20complicated%20by%20aorto-right%20ventricular%20shunt.%20The%20patient%26%23039%3Bs%20clinical%20course%20was%20followed%20up%20for%20one%20year.%5CnConclusion%3A%20This%20case%20reports%20the%20incidence%20and%20clinical%20course%20of%20one%20of%20the%20rare%20complications%20of%20TAVR%2C%20aorto-right%20ventricular%20fistula.%20Conservative%20medical%20management%20is%20appropriate%20in%20hemodynamically%20stable%20patients%20with%20this%20specific%20complication.%22%2C%22date%22%3A%22Sep%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1155%5C%2F2017%5C%2F1834394%22%2C%22ISSN%22%3A%222090-6404%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YQ6XGPLC%22%5D%2C%22dateModified%22%3A%222018-08-17T16%3A46%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22EP6NBLMQ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shatila%20et%20al.%22%2C%22parsedDate%22%3A%222016-12%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShatila%2C%20W.%2C%20Almanfi%2C%20A.%2C%20Massumi%2C%20M.%20et%20al.%20%282016%29.%20Endovascular%20treatment%20of%20superior%20vena%20cava%20syndrome%20via%20balloon-in-balloon%20catheter%20technique%20with%20a%20Palmaz%20stent.%20%26lt%3Bi%26gt%3BTex%20Heart%20Inst%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B43%26lt%3B%5C%2Fi%26gt%3B%2C%20520%26%23x2013%3B523.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-15-5479%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.14503%5C%2FTHIJ-15-5479%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Endovascular%20treatment%20of%20superior%20vena%20cava%20syndrome%20via%20balloon-in-balloon%20catheter%20technique%20with%20a%20Palmaz%20stent%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wassim%22%2C%22lastName%22%3A%22Shatila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdelkader%22%2C%22lastName%22%3A%22Almanfi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehran%22%2C%22lastName%22%3A%22Massumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhaval%20R.%22%2C%22lastName%22%3A%22Parekh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%5D%2C%22abstractNote%22%3A%22Superior%20vena%20cava%20syndrome%20is%20a%20well-known%20disease%20entity%20that%20carries%20substantial%20rates%20of%20morbidity%20and%20mortality.%20Although%20most%20cases%20of%20superior%20vena%20cava%20syndrome%20are%20secondary%20to%20a%20malignant%20process%2C%20additional%20causes%20%28such%20as%20mediastinal%20fibrosis%2C%20pacemaker%20lead%20implantation%2C%20or%20central%20venous%20catheter%20placement%29%20have%20been%20reported.%20Multiple%20treatment%20options%20include%20percutaneous%20transluminal%20angioplasty%2C%20stent%20implantation%2C%20thrombolysis%2C%20mechanical%20thrombectomy%2C%20and%20venous%20grafting.%20We%20present%20a%20case%20of%20superior%20vena%20cava%20syndrome%20in%20a%20symptomatic%2030-year-old%20woman%20who%20obtained%20complete%20relief%20of%20obstruction%20and%20marked%20symptomatic%20improvement%20through%20venoplasty%20and%20stenting%2C%20aided%20by%20our%20use%20of%20a%20balloon-in-balloon%20catheter%20system.%22%2C%22date%22%3A%22Dec%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.14503%5C%2FTHIJ-15-5479%22%2C%22ISSN%22%3A%221526-6702%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YQ6XGPLC%22%2C%22AYNRIB2F%22%2C%22K6JKEATQ%22%2C%222NK6UQ4P%22%5D%2C%22dateModified%22%3A%222021-08-21T16%3A11%3A17Z%22%7D%7D%5D%7D
Postalian, A., Kuchibhotla, S., Koneru, S. et al. (2022). A special clinical scenario for transcatheter aortic valve replacement: “iatrogenic double-outlet” left ventricle. Tex Heart Inst J 49, e227889. https://doi.org/10.14503/THIJ-22-7889.
Postalian, A., Strickman, N. E., Costello, B. T. et al. (2021). “Simple” transcatheter aortic valve replacement with conscious sedation: Safety and effectiveness in real-world practice. Tex Heart Inst J 48, e207528. https://doi.org/10.10453/THIJ-20-7528.
Kherallah, R. Y., Koneru, S., Krajcer, Z. et al. (2021). Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience. Ann Cardiothorac Surg 10, 630–640. https://doi.org/10.21037/acs-2021-tviv-131.
Kherallah, R. Y., Harrison, D., Preventza, O. et al. (2021). Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329, 50–55. https://doi.org/10.1016/j.ijcard.2020.12.054.
Geraghty, P. J., Adams, G., Schmidt, A. et al. (2021). Six-month pivotal results of tack optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries. J Vasc Surg 73, 918-929.e5. https://doi.org/10.1016/j.jvs.2020.08.135.
Geraghty, P. J., Adams, G. L., Schmidt, A. et al. (2020). Twelve-month results of Tack-optimized balloon angioplasty using the Tack endovascular system in below-the-knee arteries (TOBA II BTK). J Endovasc Ther 27, 626–636. https://doi.org/10.1177/1526602820944402.
Krajcer, Z., Wood, D. A., Strickman, N. et al. (2020). Pivotal clinical study to evaluate the safety and effectiveness of the MANTA vascular closure device during percutaneous EVAR and TEVAR procedures. J Endovasc Ther 27, 414–420. https://doi.org/10.1177/1526602820912224.
Wood, D. A., Krajcer, Z., Sathananthan, J. et al. (2019). Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device. Circ Cardiovasc Interv 12, e007258. https://doi.org/10.1161/CIRCINTERVENTIONS.119.007258.
Almanfi, A., Qurie, A. and Strickman, N. (2017). Aorto-right ventricular shunt after TAVR: rare complication of common procedure. Case Rep Cardiol 2017, 1834394. https://doi.org/10.1155/2017/1834394.
Shatila, W., Almanfi, A., Massumi, M. et al. (2016). Endovascular treatment of superior vena cava syndrome via balloon-in-balloon catheter technique with a Palmaz stent. Tex Heart Inst J 43, 520–523. https://doi.org/10.14503/THIJ-15-5479.